206 related articles for article (PubMed ID: 25742479)
1. An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.
Li K; Hüsing A; Fortner RT; Tjønneland A; Hansen L; Dossus L; Chang-Claude J; Bergmann M; Steffen A; Bamia C; Trichopoulos D; Trichopoulou A; Palli D; Mattiello A; Agnoli C; Tumino R; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HB; Gram IT; Weiderpass E; Sánchez-Cantalejo E; Chirlaque MD; Duell EJ; Ardanaz E; Idahl A; Lundin E; Khaw KT; Travis RC; Merritt MA; Gunter MJ; Riboli E; Ferrari P; Terry K; Cramer D; Kaaks R
Br J Cancer; 2015 Mar; 112(7):1257-65. PubMed ID: 25742479
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
Tsilidis KK; Allen NE; Key TJ; Dossus L; Lukanova A; Bakken K; Lund E; Fournier A; Overvad K; Hansen L; Tjønneland A; Fedirko V; Rinaldi S; Romieu I; Clavel-Chapelon F; Engel P; Kaaks R; Schütze M; Steffen A; Bamia C; Trichopoulou A; Zylis D; Masala G; Pala V; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Braem MG; Onland-Moret NC; Gram IT; Rodríguez L; Travier N; Sánchez MJ; Huerta JM; Ardanaz E; Larrañaga N; Jirström K; Manjer J; Idahl A; Ohlson N; Khaw KT; Wareham N; Mouw T; Norat T; Riboli E
Br J Cancer; 2011 Oct; 105(9):1436-42. PubMed ID: 21915124
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition.
Tsilidis KK; Allen NE; Key TJ; Dossus L; Kaaks R; Bakken K; Lund E; Fournier A; Dahm CC; Overvad K; Hansen L; Tjønneland A; Rinaldi S; Romieu I; Boutron-Ruault MC; Clavel-Chapelon F; Lukanova A; Boeing H; Schütze M; Benetou V; Palli D; Berrino F; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Braem MG; Onland-Moret NC; Gram IT; Rodríguez L; Duell EJ; Sánchez MJ; Huerta JM; Ardanaz E; Amiano P; Khaw KT; Wareham N; Riboli E
Cancer Causes Control; 2011 Aug; 22(8):1075-84. PubMed ID: 21637986
[TBL] [Abstract][Full Text] [Related]
5. An epidemiological model for prediction of endometrial cancer risk in Europe.
Hüsing A; Dossus L; Ferrari P; Tjønneland A; Hansen L; Fagherazzi G; Baglietto L; Schock H; Chang-Claude J; Boeing H; Steffen A; Trichopoulou A; Bamia C; Katsoulis M; Krogh V; Palli D; Panico S; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Gram IT; Ardanaz E; Obón-Santacana M; Navarro C; Sánchez-Cantalejo E; Etxezarreta N; Allen NE; Khaw KT; Wareham N; Rinaldi S; Romieu I; Merritt MA; Gunter M; Riboli E; Kaaks R
Eur J Epidemiol; 2016 Jan; 31(1):51-60. PubMed ID: 25968175
[TBL] [Abstract][Full Text] [Related]
6. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Lahmann PH; Cust AE; Friedenreich CM; Schulz M; Lukanova A; Kaaks R; Lundin E; Tjønneland A; Halkjaer J; Severinsen MT; Overvad K; Fournier A; Chabbert-Buffet N; Clavel-Chapelon F; Dossus L; Pischon T; Boeing H; Trichopoulou A; Lagiou P; Naska A; Palli D; Grioni S; Mattiello A; Tumino R; Sacerdote C; Redondo ML; Jakszyn P; Sánchez MJ; Tormo MJ; Ardanaz E; Arriola L; Manjer J; Jirström K; Bueno-de-Mesquita HB; May AM; Peeters PH; Onland-Moret NC; Bingham S; Khaw KT; Allen NE; Spencer E; Rinaldi S; Slimani N; Chajes V; Michaud D; Norat T; Riboli E
Int J Cancer; 2010 May; 126(10):2404-15. PubMed ID: 19821492
[TBL] [Abstract][Full Text] [Related]
7. An epidemiologic study of ovarian cancer. Part 11: Oral contraceptive use and menstrual events.
Badawy YA; Bayoumi DM
J Egypt Public Health Assoc; 1992; 67(5-6):579-91. PubMed ID: 1294683
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Schrijver LH; Antoniou AC; Olsson H; Mooij TM; Roos-Blom MJ; Azarang L; Adlard J; Ahmed M; Barrowdale D; Davidson R; Donaldson A; Eeles R; Evans DG; Frost D; Henderson A; Izatt L; Ong KR; Bonadona V; Coupier I; Faivre L; Fricker JP; Gesta P; van Engelen K; Jager A; Menko FH; Mourits MJE; Singer CF; Tan YY; Foretova L; Navratilova M; Schmutzler RK; Ellberg C; Gerdes AM; Caldes T; Simard J; Olah E; Jakubowska A; Rantala J; Osorio A; Hopper JL; Phillips KA; Milne RL; Beth Terry M; Noguès C; Engel C; Kast K; Goldgar DE; van Leeuwen FE; Easton DF; Andrieu N; Rookus MA;
Am J Obstet Gynecol; 2021 Jul; 225(1):51.e1-51.e17. PubMed ID: 33493488
[TBL] [Abstract][Full Text] [Related]
9. Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition.
Braem MG; Onland-Moret NC; Schouten LJ; Kruitwagen RF; Lukanova A; Allen NE; Wark PA; Tjønneland A; Hansen L; Braüner CM; Overvad K; Clavel-Chapelon F; Chabbert-Buffet N; Teucher B; Floegel A; Boeing H; Trichopoulou A; Adarakis G; Plada M; Rinaldi S; Fedirko V; Romieu I; Pala V; Galasso R; Sacerdote C; Palli D; Tumino R; Bueno-de-Mesquita HB; Gram IT; Gavrilyuk O; Lund E; Sánchez MJ; Bonet C; Chirlaque MD; Larrañaga N; Gurrea AB; Quirós JR; Idahl A; Ohlson N; Lundin E; Jirström K; Butt S; Tsilidis KK; Khaw KT; Wareham N; Riboli E; Kaaks R; Peeters PH
PLoS One; 2012; 7(5):e37141. PubMed ID: 22623987
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for ovarian cancer: a case-control study.
Booth M; Beral V; Smith P
Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
[TBL] [Abstract][Full Text] [Related]
11. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone replacement therapy and risk of ovarian cancer.
Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
[TBL] [Abstract][Full Text] [Related]
15. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
[TBL] [Abstract][Full Text] [Related]
16. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S; Dossus L; Lukanova A; Peeters PH; Allen NE; Key T; Bingham S; Khaw KT; Trichopoulos D; Trichopoulou A; Oikonomou E; Pera G; Larrañaga N; Martinez-Garcia C; Ardanaz E; Quirós JR; Tormo MJ; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Linseisen J; Schulz M; Boeing H; van Gils CH; Bueno-de-Mesquita BH; Pala V; Palli D; Panico S; Tumino R; Vineis P; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC; Lundin E; Agren A; Berglund G; Manjer J; Kumle M; Lund E; Slimani N; Saracci R; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):23-9. PubMed ID: 17220328
[TBL] [Abstract][Full Text] [Related]
17. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
Gram IT; Lukanova A; Brill I; Braaten T; Lund E; Lundin E; Overvad K; Tjønneland A; Clavel-Chapelon F; Chabbert-Buffet N; Bamia C; Trichopoulou A; Zylis D; Masala G; Berrino F; Galasso R; Tumino R; Sacerdote C; Gavrilyuk O; Kristiansen S; Rodríguez L; Bonet C; Huerta JM; Barricarte A; Sánchez MJ; Dorronsoro M; Jirström K; Almquist M; Idahl A; Bueno-de-Mesquita HB; Braem M; Onland-Moret C; Tsilidis KK; Allen NE; Fedirko V; Riboli E; Kaaks R
Int J Cancer; 2012 May; 130(9):2204-10. PubMed ID: 21678398
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of recreational physical activity and ovarian cancer.
Bertone ER; Willett WC; Rosner BA; Hunter DJ; Fuchs CS; Speizer FE; Colditz GA; Hankinson SE;
J Natl Cancer Inst; 2001 Jun; 93(12):942-8. PubMed ID: 11416116
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
